M. Guaraldi

960 citations

27 papers · 566 indexed · h-index 14

Impact in

Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
Oncology top 10%
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology

Papers in ⓘ

Otorhinolaryngology 6
- Head and Neck Cancer Studies 6
Oncology 20
- Lung Cancer Research Studies 10
- Cancer Treatment and Pharmacology 8
- Cancer Diagnosis and Treatment 3

Co-authors: Andrea Martoni (17 shared papers)F Pannuti (17 shared papers)Barbara Melotti (5 shared papers)E Piana (6 shared papers)Adriano Paccagnella (5 shared papers)H. Koussis (5 shared papers)Andrea Bonetti (5 shared papers)Maria Grazia Ghi (4 shared papers)
Journals: Annals of Oncology (4 papers)Journal of Clinical Oncology (3 papers)Journal of Chemotherapy (3 papers)Lung Cancer (2 papers)European Journal of Cancer (2 papers)
Partner nations: Italy

In The Last Decade

M. Guaraldi

26 papers receiving 533 citations

Peers

Countries citing papers authored by M. Guaraldi

Since Specialization

Citations

This map shows the geographic impact of M. Guaraldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Guaraldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Guaraldi more than expected).

Fields of papers citing papers by M. Guaraldi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Guaraldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Guaraldi. The network helps show where M. Guaraldi may publish in the future.

Co-authors

The 25 scholars most cited alongside M. Guaraldi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Guaraldi Line = papers co-authored together M. Guaraldi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study Annals of Oncology ·Adriano Paccagnella, Maria Grazia Ghi, L. Loreggian, Alberto Buffoli, H. Koussis, Carlo A. Mione, Andrea Bonetti, Franco Campostrini, G Gardani, Antonio Ardizzoia, Davide Dondi, M. Guaraldi, Rossana Cavallo, L. Tomio, Alessandro Gava	2009	127
2	Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer European Journal of Cancer ·Andrea Martoni, Antonella Marino, Francesca Sperandi, S. Giaquinta, Francesca Di Fabio, Barbara Melotti, M. Guaraldi, Giuseppe Palomba, P. Preti, Antonino Petralia, Fabrizio Artioli, Vincenzo Picece, A. Farris, LG Mantovani	2004	61
3	Concomitant chemoradiation (CRT) or cetuximab/RT (CET/RT) versus induction Docetaxel/ Cisplatin/5-Fluorouracil (TPF) followed by CRT or CET/RT in patients with Locally Advanced Squamous Cell Carcinoma of Head and Neck (LASCCHN). A randomized phase III factorial study (NCT01086826). Journal of Clinical Oncology ·Maria Grazia Ghi, Adriano Paccagnella, Daris Ferrari, Paolo Foa, Maria Cossu Rocca, Elena Verri, Franco Morelli, Giuseppe Azzarello, Consuelo D'Ambrosio, Giorgio Cruciani, M. Guaraldi, Elena Massa, C. Rossetto, Andrea Bonetti, Salvatore Siena, Vincenzo Minotti, H. Koussis, Gabriella Pieri, Vittorio Baggio, Irene Floriani, (unknown)	2014	48
4	Controlled Clinical Study on the Use of Dichloromethylene Diphosphonate in Patients with Breast Carcinoma Metastasizing to the Skeleton Oncology ·Andrea Martoni, M. Guaraldi, P. Della Camera, Renato Biagi, Susanna Marri, Franco Beghè, F Pannuti	1991	41
5	Prospective Phase II Study of Single-Agent Gemcitabine in Untreated Elderly Patients With Stage IIIB/IV Non–Small-Cell Lung Cancer American Journal of Clinical Oncology ·Andrea Martoni, Francesca Di Fabio, M. Guaraldi, E Piana, R Ramini, G. Lelli, Giuseppe Palomba, Fabrizio Artioli, Elena Bandieri, G. Robustelli della Cuna, P. Preti	2001	33
6	Idarubicin metabolism and pharmacokinetics after intravenous and oral administration in cancer patients: a crossover study Cancer Chemotherapy and Pharmacology ·Carlo Maurizio Camaggi, Elena Strocchi, Patrizia Carisi, Andrea Martoni, A Tononi, M. Guaraldi, Margherita Strolin‐Benedetti, Constantin Efthymiopoulos, F Pannuti	1992	30
7	Activity of high-dose epirubicin in advanced non-small cell lung cancer European Journal of Cancer and Clinical Oncology ·Andrea Martoni, Barbara Melotti, M. Guaraldi, F Pannuti	1991	26
8	Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer Lung Cancer ·Andrea Martoni, M. Guaraldi, E Piana, Elena Strocchi, Antonino Petralia, L. Busutti, P. Preti, G. Robustelli della Cuna, M Raimondi, Giuseppe Ferrara, Giuseppe Palomba, G. Lelli, Vincenzo Picece, E. Recaldin, Orazio Caffo, G. Ambrosini, Giuseppina Sarobba, A. Farris, F Pannuti	1998	25
9	Comparative Phase II Study of Idarubicin versus Doxorubicin in Advanced Breast Cancer Oncology ·Andrea Martoni, E Piana, M. Guaraldi, Giuseppina Cilenti, A. Farris, F Saccani, Giorgio Becchi, F Pannuti	1990	24
10	Combination Chemotherapy With Mitoxantrone, Methotrexate, and Mitomycin (MMM Regimen) in Malignant Pleural Mesothelioma American Journal of Clinical Oncology ·Carmine Pinto, Antonella Marino, M. Guaraldi, Barbara Melotti, E Piana, Andrea Martoni, F Pannuti	2001	23
11	A phase II-III study comparing concomitant chemoradiotherapy (CRT) versus cetuximab/RT (CET/RT) with or without induction docetaxel/cisplatin/5-fluorouracil (TPF) in locally advanced head and neck squamous cell carcinoma (LASCCHN): Efficacy results (NCT01086826). Journal of Clinical Oncology ·Maria Grazia Ghi, Adriano Paccagnella, Daris Ferrari, Paolo Foa, Maria Cossu Rocca, Elena Verri, Evaristo Maiello, Giuseppe Azzarello, Consuelo D'Ambrosio, Cláudia Casanova, M. Guaraldi, Giovanni Mantovani, C. Rossetto, Andrea Bonetti, Tiziana Cipani, Lucio Crinò, H. Koussis, Gabriella Pieri, Alessandro Gava, Irene Floriani, (unknown)	2013	20
12	An open randomised cross-over study on granisetron versus ondansetron in the prevention of acute emesis induced by moderate dose cisplatin-containing regimens European Journal of Cancer ·Andrea Martoni, Bruna Angelelli, M. Guaraldi, Elena Strocchi, F Pannuti	1996	17
13	High-dose epiribicin for untreated patients with advanced tumours: a phase I study European Journal of Cancer and Clinical Oncology ·A. Martoni, Barbara Melotti, M. Guaraldi, M. A. Pacciarini, A. Riva, F Pannuti	1990	16
14	A phase II study of high-dose epirubicin plus cisplatinum in advanced non-small-cell lung cancer (NSCLC) Annals of Oncology ·Andrea Martoni, M. Guaraldi, Marco Casadio, F Pannuti, L. Busutti	1992	14
15	Cetuximab/radiotherapy (CET+RT) versus concomitant chemoradiotherapy (cCHT+RT) with or without induction docetaxel/cisplatin/5-fluorouracil (TPF) in locally advanced head and neck squamous cell carcinoma (LASCCHN): Preliminary results on toxicity of a randomized, 2x2 factorial, phase II-III study (NCT01086826). Journal of Clinical Oncology ·Maria Grazia Ghi, Adriano Paccagnella, Daris Ferrari, Paolo Foa, Franco Nolè, Franco Morelli, Giuseppe Azzarello, Consuelo D'Ambrosio, Cláudia Casanova, M. Guaraldi, Giovanni Mantovani, C. Rossetto, Andrea Bonetti, Salvatore Siena, Lucio Crinò, Alberto Buffoli, H. Koussis, Gabriella Pieri, Alessandro Gava, Irene Floriani, (unknown)	2012	11
16	Weekly regimen of 5-FU vs 5-FU + intermediate dose folinic acid in the treatment of advanced colorectal cancer. PubMed ·Andrea Martoni, A. Cricca, M. Guaraldi, M Covizzi, A. Farris, F Pannuti	1992	10
17	Comparative crossover trial of two intravenous doses of granisetron (1 mg vs 3 mg) + dexamethasone in the prevention of acute cis-platinum-induced emesis. PubMed ·Andrea Martoni, E Piana, Enrico Strocchi, Bruna Angelelli, M. Guaraldi, Claudio Zamagni, Camaggi Cm, F Pannuti	1998	8
18	Planned sequence of gemcitabine followed by vinorelbine in the treatment of elderly patients with advanced non-small cell lung cancer. PubMed ·Andrea Martoni, Francesca Di Fabio, Barbara Melotti, S. Giaquinta, M. Guaraldi	2006	7
19	Anthracyclines in non-small-cell lung cancer: Do they have a therapeutic role? Annals of Oncology ·Andrea Martoni, M. Guaraldi, E Piana	1999	5
20	5-Fluorouracil + folinic acid with cisplatinum and bleomyein in the treatment of advanced head and neck squamous cell carcinoma Annals of Oncology ·M. Guaraldi, Andrea Martoni, A. Tononi, L Occhiuzzi, Umberto Caliceti, D Dall’Olio, P Laudadio, F Pannuti	1991	5

About M. Guaraldi

M. Guaraldi is a scholar working on Otorhinolaryngology, Oncology, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Nephrology, having authored 27 papers that have together received 566 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Lung Cancer Research Studies (10 papers), Cancer Treatment and Pharmacology (8 papers), Head and Neck Cancer Studies (6 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers), Cancer therapeutics and mechanisms (3 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Otorhinolaryngology (203 citations), Oncology (332 citations), Pulmonary and Respiratory Medicine (261 citations), Surgery (182 citations) and Cardiology and Cardiovascular Medicine (37 citations). M. Guaraldi has collaborated with scholars based in Italy. Frequent co-authors include Andrea Martoni, F Pannuti, Barbara Melotti, E Piana, Adriano Paccagnella, H. Koussis, Andrea Bonetti, Maria Grazia Ghi, A. Farris and Alessandro Gava. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Journal of Chemotherapy, Lung Cancer and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact